Skip to content

BOUSSEMAERE ELIEN DR.

Active
Private limited companyfounded 2024active for 2 yearsLijnwaadstraat 1A, 8900 Ieper, BelgiumKBO/BCE: BE 1006.587.608
Summary

BOUSSEMAERE ELIEN DR. has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €140,808 and a net result of €83,337. Its solvency ranks better than 90% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 29-02-2024 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.356.976.769 8900 Ieper, since 29-02-2024
Financial year end
30 September
Peppol
Reachable since 09-12-2024

Board and ownership

Board

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€118,292
▲ 78.7%
Turnover
≈ €220,000
estimated
Profit
€83,337
▲ 58.8%
Equity
€140,808
▲ 145%
Total assets
€149,619
▲ 149%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 16.11, cash €126,335Equity €140,808 (94.1% of total assets)Figures for financial year 2025 (filed on 10-04-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 88% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 94.1% of total assets
Liquidity 100=
short-term debt 5.9% · cash 84.4%
Profitability 100=
return on assets 55.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 03-2025: 0.3%highest value 04-2025: < 0.1%▼ -0.3 percentage points vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €13,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 16.11 (27.81 in 2024), above the usual 1.5. Short-term debt is 5.9% and cash 84.4% of total assets. 5.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 93% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 16.11, cash €126,335
NBB · annual accounts
lowers risk · Equity €140,808 (94.1% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 10-04-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 09-04-2026, 21 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
21 days early
2024
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 32 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end02-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Positive: Equity rose in 2025from €57,471 to €140,808 ▲ 145% View
  • Positive: Higher solvency than 90% of companies in human healthsector median 63.0% · 20,700 companies 94.1% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: BOUSSEMAERE Elien Veerle Nele (director)
All 4 events

Comparable companies

These companies have the same main activity as BOUSSEMAERE ELIEN DR.: general medical practice (NACE 86210). They are comparable in size and age: total assets between €138,000 and €164,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
BOUSSEMAERE ELIEN DR. Ieper€149,619€118,292
DR. LINDE LUCIE VH Jabbeke€164,377€124,282
Wim Florus Essen€145,292€113,279
Dr. A. Boel Gavere€148,631€110,516
CABINET MEDICAL ALEXANDRE DEGEIMBRE Beauraing€163,889€115,895
Groepspraktijk De ELM Merchtem€140,142€113,418
Dokter Shiri Pegah Destelbergen€138,361€127,493
Full comparison

Key facts about BOUSSEMAERE ELIEN DR.

What is the company number of BOUSSEMAERE ELIEN DR.?
The company number of BOUSSEMAERE ELIEN DR. is 1006.587.608. The VAT number is the same number with BE in front: BE 1006.587.608.
Where is BOUSSEMAERE ELIEN DR. based?
The registered office is at Lijnwaadstraat 1A, 8900 Ieper.Company details
What does BOUSSEMAERE ELIEN DR. do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of BOUSSEMAERE ELIEN DR.?
The legal form of BOUSSEMAERE ELIEN DR. is Private limited company (BV).
When was BOUSSEMAERE ELIEN DR. founded?
BOUSSEMAERE ELIEN DR. was founded on 29-02-2024.
Is BOUSSEMAERE ELIEN DR. still active?
Yes, BOUSSEMAERE ELIEN DR. is an active enterprise in the KBO register.
What is the turnover of BOUSSEMAERE ELIEN DR.?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €118,292 and 30 comparable companies (NACE 86210). It probably lies between €170,000 and €270,000.Financials
Is BOUSSEMAERE ELIEN DR. profitable?
In financial year 2025, BOUSSEMAERE ELIEN DR. made a profit of €83,337.
Where can I find the annual accounts of BOUSSEMAERE ELIEN DR.?
BOUSSEMAERE ELIEN DR. filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BOUSSEMAERE ELIEN DR. due?
BOUSSEMAERE ELIEN DR. must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.